Newbridge Financial Services Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,500
| Closed | -$659 | – | 1508 |
|
|
2022
Q4 | $659 | Hold |
12,500
| – | – | ﹤0.01% | 1344 |
|
|
2022
Q3 | $15K | Sell |
12,500
-653
| -5% | -$1.02K | 0.01% | 789 |
|
|
2022
Q2 | $24K | Buy |
13,153
+6,500
| +98% | +$9.59K | 0.01% | 612 |
|
|
2022
Q1 | $13K | Hold |
6,653
| – | – | 0.01% | 873 |
|
|
2021
Q4 | $18K | Hold |
6,653
| – | – | 0.01% | 769 |
|
|
2021
Q3 | $30K | Buy |
6,653
+3,500
| +111% | +$16.9K | 0.02% | 558 |
|
|
2021
Q2 | $18K | Hold |
3,153
| – | – | 0.01% | 815 |
|
|
2021
Q1 | $22K | Buy |
3,153
+1,653
| +110% | +$11.1K | 0.02% | 674 |
|
|
2020
Q4 | $7K | Hold |
1,500
| – | – | 0.01% | 804 |
|
|
2020
Q3 | $9K | Buy |
+1,500
| New | +$8.97K | 0.01% | 711 |
|